131 related articles for article (PubMed ID: 11234759)
1. Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.
Cyr M; Morissette M; Landry M; Di Paolo T
Neuroreport; 2001 Mar; 12(3):535-9. PubMed ID: 11234759
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.
Cyr M; Thibault C; Morissette M; Landry M; Di Paolo T
Neuropsychopharmacology; 2001 Aug; 25(2):242-57. PubMed ID: 11425508
[TBL] [Abstract][Full Text] [Related]
3. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.
Landry M; Lévesque D; Di Paolo T
Neuroendocrinology; 2002 Oct; 76(4):214-22. PubMed ID: 12411738
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
Landry M; Di Paolo T
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
Sato M; Rippy MK; Bryant HU
FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
[TBL] [Abstract][Full Text] [Related]
8. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain.
Cyr M; Landry M; Di Paolo T
Neuropsychopharmacology; 2000 Jul; 23(1):69-78. PubMed ID: 10869887
[TBL] [Abstract][Full Text] [Related]
9. Selective estrogen receptor-alpha but not -beta agonist treatment modulates brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Le Saux M; Estrada-Camarena E; Di Paolo T
J Neurosci Res; 2006 Oct; 84(5):1076-84. PubMed ID: 16937413
[TBL] [Abstract][Full Text] [Related]
10. Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors.
Cyr M; Ghribi O; Thibault C; Morissette M; Landry M; Di Paolo T
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):153-61. PubMed ID: 11744083
[TBL] [Abstract][Full Text] [Related]
11. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain.
Cyr M; Ghribi O; Di Paolo T
J Neuroendocrinol; 2000 May; 12(5):445-52. PubMed ID: 10792584
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
13. Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens.
Le Saux M; Di Paolo T
Psychoneuroendocrinology; 2005 Apr; 30(3):251-60. PubMed ID: 15511599
[TBL] [Abstract][Full Text] [Related]
14. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.
Shughrue PJ; Lane MV; Merchenthaler I
Endocrinology; 1997 Dec; 138(12):5476-84. PubMed ID: 9389534
[TBL] [Abstract][Full Text] [Related]
15. In vivo occupancy of female rat brain estrogen receptors by 17beta-estradiol and tamoxifen.
Pareto D; Alvarado M; Hanrahan SM; Biegon A
Neuroimage; 2004 Nov; 23(3):1161-7. PubMed ID: 15528115
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions.
Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N
Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501
[TBL] [Abstract][Full Text] [Related]
17. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats.
Wu X; Glinn MA; Ostrowski NL; Su Y; Ni B; Cole HW; Bryant HU; Paul SM
Brain Res; 1999 Nov; 847(1):98-104. PubMed ID: 10564741
[TBL] [Abstract][Full Text] [Related]
19. Selective estrogen receptor modulator effects in the rat brain.
Zhou W; Koldzic-Zivanovic N; Clarke CH; de Beun R; Wassermann K; Bury PS; Cunningham KA; Thomas ML
Neuroendocrinology; 2002 Jan; 75(1):24-33. PubMed ID: 11810032
[TBL] [Abstract][Full Text] [Related]
20. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement.
Sumner BE; Grant KE; Rosie R; Hegele-Hartung C; Fritzemeier KH; Fink G
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):119-28. PubMed ID: 10581405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
